trending Market Intelligence /marketintelligence/en/news-insights/trending/tANj5Nf7RHioZECNu9Kq5A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Fujifilm confirms ¥179B deal for Hitachi's diagnostic imaging unit

Case Study: Transforming Sales Enablement Data at a Global Advertising and Media Firm

Impact of COVID 19 on US Video Entertainment Trends

Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19

Mining Exploration Insights – May 2020


Fujifilm confirms ¥179B deal for Hitachi's diagnostic imaging unit

FUJIFILM Holdings Corp. subsidiary Fujifilm Corp. agreed to acquire Hitachi Ltd.'s diagnostic imaging-related unit to expand its healthcare business for an estimated ¥179 billion, confirming media reports from a day earlier.

The deal is expected to complete in July 2020, subject to customary closing conditions and regulatory approvals.

With the deal, Fujifilm hopes to enhance its capability to offer a range of solutions to medical institutions, including MRI diagnostics imaging, medical IT, in-vitro diagnostics and endoscopy. In addition, Fujifilm plans to create a new business that can generate synergies between its medical systems business and other businesses in the healthcare segment.

Fujifilm said there will also be cross-selling opportunities and that it will be able to expand into new areas, including AI-supported diagnosis and AI-supported maintenance.

The purchase price is subject to the target business' level of cash, net debt and working capital at the timing of closing.

As of Dec. 17, US$1 was equivalent to ¥109.53.